Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 9—September 2007

Letter

TaqMan Assay for Swedish Chlamydia trachomatis Variant

Arnold Catsburg*1, Laura van Dommelen†1, Vitaly Smelov‡§, Henry J.C. de Vries¶#, Alevtina Savitcheva‡, Marius Domeika**, Björn Herrmann††, Sander Ouburg*, Christian J.P.A. Hoebe‡‡, Anders Nilsson††, Paul H.M. Savelkoul*, and Servaas A. Morré*†§§Comments to Author 
Author affiliations: *VU University Medical Center, Amsterdam, the Netherlands; †Academic Hospital Maastricht, Maastricht, the Netherlands; ‡D.O. Ott Research Institute of Obstetrics and Gynaecology, St. Petersburg, Russia; §St. Petersburg State University, St. Petersburg, Russia; ¶Health Service Amsterdam, Amsterdam, the Netherlands; #University of Amsterdam, Amsterdam, the Netherlands; **Uppsala University, Uppsala, Sweden; ††Uppsala University Hospital, Uppsala, Sweden; ‡‡South Limburg Public Health Service, Heerlen, the Netherlands; §§City of Hope and Beckman Research Institute, Duarte, California, USA;

Main Article

Table

Published studies and the current study on screening for the swCT variant*

Location Ct+, 
no. detected swCT variant, 
no. detected Reference
Amsterdam, the Netherlands 75 ND (3)
Dublin, Ireland 750 ND (4)
Oslo, Norway† 47 2 (5)
St. Petersburg, Russia 152 ND This study
Heerlen, the Netherlands 57 ND This study
Amsterdam, the Netherlands 30 ND This study

*swCT, Swedish Chlamydia trachomatis variant identified in Halland County, Sweden; Ct+, C. trachomatis DNA; ND, not detected.
†2 female patients: 1 originally from Sweden, 1 from Norway.

Main Article

1These authors contributed equally to the study.

TOP